Canada markets close in 6 hours 29 minutes

Cellectar Biosciences, Inc. (CLRB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.10000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 100.01M
Enterprise Value 97.06M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.67
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.50

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52-Week Change 3100.00%
S&P500 52-Week Change 324.19%
52 Week High 34.4500
52 Week Low 31.3300
50-Day Moving Average 33.6092
200-Day Moving Average 32.7868

Share Statistics

Avg Vol (3 month) 31.03M
Avg Vol (10 day) 3896.16k
Shares Outstanding 532.26M
Implied Shares Outstanding 632.69M
Float 824.21M
% Held by Insiders 13.56%
% Held by Institutions 126.40%
Shares Short (Apr 15, 2024) 42.19M
Short Ratio (Apr 15, 2024) 41.96
Short % of Float (Apr 15, 2024) 46.81%
Short % of Shares Outstanding (Apr 15, 2024) 46.80%
Shares Short (prior month Mar 15, 2024) 41.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 17, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul 22, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-144.66%
Return on Equity (ttm)-536.81%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -38.77M
Net Income Avi to Common (ttm)-37.98M
Diluted EPS (ttm)-3.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.56M
Total Cash Per Share (mrq)0.3
Total Debt (mrq)552.98k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.81
Book Value Per Share (mrq)-0.36

Cash Flow Statement

Operating Cash Flow (ttm)-32.38M
Levered Free Cash Flow (ttm)-15.44M